human proximal renal tubular epithelial cell line (ATCC)
Structured Review
Human Proximal Renal Tubular Epithelial Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 4553 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+renal+tubular+epithelial+cell+line+hk+2+cells/HK-2/pm42262012-93-0-11
Average 99 stars, based on 4553 article reviews
Images
Related Articles
Cell Culture:Article Title: Mechanism of ultrasound-guided renal parenchymal injection of MSCs for the treatment of chronic kidney disease: down-regulated SGK1 promotes M2 macrophage polarization. Article Snippet: .. Human umbilical cord MSCs (MEISEN, CTCC-159-HUM), human acute monocytic leukemia cell line THP-1 (MEISEN, CTCC-001-0044) and Article Title: Mechanism of ultrasound-guided renal parenchymal injection of MSCs for the treatment of chronic kidney disease: down-regulated SGK1 promotes M2 macrophage polarization Article Snippet: .. Human umbilical cord MSCs (MEISEN, CTCC-159-HUM), human acute monocytic leukemia cell line THP-1 (MEISEN, CTCC-001-0044) and Article Title: Telmisartan attenuates diabetic nephropathy progression by inhibiting the dimerization of angiotensin type-1 receptor and adiponectin receptor-1. Article Snippet: Accepted Manuscript Telmisartan attenuates diabetic nephropathy progression by inhibiting the dimerization of angiotensin type-1 receptor and adiponectin receptor-1 Dongqing Zha, Tao Yao, Liping Bao, Ping Gao, Xiaoyan Wu PII: S0024-3205(19)30057-8 DOI: https://doi.org/10.1016/j.lfs.2019.01.044 Reference: LFS 16219 To appear in: Life Sciences Received date: 29 August 2018 Revised date: 25 January 2019 Accepted date: 26 January 2019 Please cite this article as: D. Zha, T. Yao, L. Bao, et al., Telmisartan attenuates diabetic nephropathy progression by inhibiting the dimerization of angiotensin type-1 receptor and adiponectin receptor-1, Life Sciences, https://doi.org/10.1016/j.lfs.2019.01.044 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Recombinant:Article Title: Telmisartan attenuates diabetic nephropathy progression by inhibiting the dimerization of angiotensin type-1 receptor and adiponectin receptor-1. Article Snippet: Accepted Manuscript Telmisartan attenuates diabetic nephropathy progression by inhibiting the dimerization of angiotensin type-1 receptor and adiponectin receptor-1 Dongqing Zha, Tao Yao, Liping Bao, Ping Gao, Xiaoyan Wu PII: S0024-3205(19)30057-8 DOI: https://doi.org/10.1016/j.lfs.2019.01.044 Reference: LFS 16219 To appear in: Life Sciences Received date: 29 August 2018 Revised date: 25 January 2019 Accepted date: 26 January 2019 Please cite this article as: D. Zha, T. Yao, L. Bao, et al., Telmisartan attenuates diabetic nephropathy progression by inhibiting the dimerization of angiotensin type-1 receptor and adiponectin receptor-1, Life Sciences, https://doi.org/10.1016/j.lfs.2019.01.044 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. |
